In this study, we generated transgene-free iPSCs from the fibroblasts of a CS patient bearing newly identified heterozygous disease-causing mutations in the ERCC6 gene and obtained isogenic gene-corrected iPSCs using the CRISPR/Cas9 system. This evidence concerns the gene ERCC6 and Cowden syndrome 1.